Sage Infusion Amends Exempt Securities Offering (Form D/A)

TL;DR

**Sage Infusion just updated its private funding details, so keep an eye on their capital structure.**

AI Summary

Sage Infusion LLC, a Florida-incorporated company, filed an amended Form D/A on March 24, 2026, updating a previous notice of an exempt offering of securities. This filing, with an accession number of 0001014108-26-000020, indicates a change or correction to an earlier private placement. For investors, this matters because it provides updated information on how Sage Infusion is raising capital outside of public markets, which can impact future dilution or the company's financial health.

Why It Matters

This amendment provides updated details on Sage Infusion's private fundraising efforts, which can affect the company's capital structure and potential future value for shareholders.

Risk Assessment

Risk Level: low — This filing is an amendment to a notice of exempt offering, which is a routine update and does not inherently signal high risk.

Analyst Insight

An investor should review the full D/A filing to understand the specific changes made to the exempt offering, as these details could impact the company's valuation or future capital needs. This is an amendment, so comparing it to the original Form D would be crucial.

Key Numbers

• 0001014108-26-000020 — SEC Accession No. (Unique identifier for this specific filing)
• 2026-03-24 — Filing Date (Date the D/A form was filed and accepted)
• 021-577380 — File No. (SEC file number for the offering)

Key Players & Entities

• Sage Infusion LLC (company) — the filer of the D/A form
• 0002122788 (company) — CIK of Sage Infusion LLC
• 0001014108-26-000020 (dollar_amount) — SEC Accession No. for the filing
• March 24, 2026 (person) — Filing Date and Accepted Date
• Florida (company) — State of Incorporation for Sage Infusion LLC

FAQ

Key Financial Figures

• $1 — enues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,
• $1,000,000 — No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,
• $5,000,000 — Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001
• $1,000,001 — e   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000
• $5,000,001 — $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
• $25,000,000 — $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001
• $25,000,001 — $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
• $50,000,000 — 5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,0
• $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $1
• $50,000,001 — 0,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   O

Filing Documents

• primary_doc.html (D/A)
• primary_doc.xml (D/A) — 7KB
• 0001014108-26-000020.txt ( ) — 8KB

From the Filing

Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership   Limited Liability Company   General Partnership   Business Trust Other   Name of Issuer   Sage Infusion LLC Jurisdiction of Incorporation/Organization FLORIDA   Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year)   Yet to Be Formed           2. Principal Place of Business and Contact Information Name of Issuer   Sage Infusion LLC Street Address 1 Street Address 2   333 3RD AVE N   SUITE 413   ST. PETERSBURG   FLORIDA     33701   813-775-9997   3. Related Persons Last Name First Name Middle Name Clements Matthew Byron Street Address 1 Street Address 2   333 3rd Ave N     Suite 413   St. Petersburg   FLORIDA   33701   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary)   Last Name First Name Middle Name Manzar Shayan Street Address 1 Street Address 2   333 3rd Ave N     Suite 413   St. Petersburg   FLORIDA   33701   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary)   Last Name First Name Middle Name Mayer Joseph Street Address 1 Street Address 2   800 South Street     Suite 200   Waltham   MASSACHUSETTS   02453   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary)   Last Name First Name Middle Name Rademacher Joshua Street Address 1 Street Address 2   847 S. Newport Avenue       Tampa   FLORIDA   33606   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary)   4. Industry Group   Agriculture Banking & Financial Services     Commercial Banking     Insurance   Investing     Investment Banking     Pooled Investment Fund   Other Banking & Financial Services   Business Services Energy     Coal Mining     Electric Utilities     Energy Conservation     Environmental Services     Oil & Gas     Other Energy Health Care     Biotechnology     Health Insurance     Hospitals & Physicians     Pharmaceuticals     Other Health Care                         Manufacturing Real Estate   Commercial   Construction   REITS & Finance   Residential Other Real Estate   Retailing Restaurants Technology   Computers   Telecommunications   Other Technology Travel   Airlines & Airports   Lodging & Conventions   Tourism & Travel Services   Other Travel Other        5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   Over $100,000,000   Decline to Disclose   Decline to Disclose   Not Applicable   Not Applicable   6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b)         Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c)     7. Type of Filing   New Notice Date of First Sale   2026-03-09   First Sale Yet to Occur   Amendment     8. Duration of Offering Does the Issuer intend this offering to last more than one year?   Yes   No     9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)       10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?   Yes   No Clarification of Response (if Necessary)       11. Minimum Investment Minimum investment accepted from any outside investor $   0 USD 12. Sales Compensation Recipient   Recipient CRD Number None     (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number  None     Street Address 1 Street Address 2             13. Offering and Sales Amounts   Total Offering Amount $ 24687500 USD Indefinite Total Amount Sold $ 11750000 USD Total Remaining to be Sold $ 12937500 USD Indefinite Clarification of Response (if Necessary)      14. Investors Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have inves

View Full Filing

View this D/A filing on SEC EDGAR